Calycosin Attenuates Endoplasmic Reticulum Stress Injury in Human Renal Glomerular Endothelial Cells by Inhibiting

Yutian Wang1, Xiaolin Bai1, Ruixia Pei1

  • 1Department of Endocrinology, Rheumatology and Immunology, Xi'an Affiliated Hospital of Shaanxi University of Chinese Medicine (Xi'an Hospital of Traditional Chinese Medicine), Xi'an, Shaanxi, China.

Abstract

Insights

Calycosin, derived from Mongolian Milkvetch Root, protects kidney cells from high glucose damage by reducing endoplasmic reticulum stress via SRC/SYK-dependent reactive oxygen species (ROS) pathways. This study highlights calycosin

Area of Science:

  • Nephrology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetic nephropathy (DN) is a severe complication linked to endoplasmic reticulum (ER) stress.
  • Calycosin, an isoflavone from Mongolian Milkvetch Root, shows potential in mitigating DN.
  • The mechanism may involve targeting SRC/Spleen Tyrosine Kinase (SYK)-dependent Reactive Oxygen Species (ROS)-mediated ER stress.

Purpose of the Study:

  • To investigate the protective effects of calycosin on high glucose-induced ER stress in Human Renal Glomerular Endothelial Cells (HRGECs).
  • To elucidate the role of SRC/SYK-dependent ROS signaling in calycosin's therapeutic action against DN-related cellular injury.

Main Methods:

  • HRGECs were exposed to high glucose and treated with calycosin or SRC overexpression plasmids.
  • Quantitative real-time PCR and Western blot analyzed gene and protein expression.
  • Cell viability, cytotoxicity, apoptosis, and ROS levels were quantified using standard assays.

Main Results:

  • Calycosin reversed high glucose-induced suppression of HRGEC viability, cytotoxicity, apoptosis, and ROS production.
  • Calycosin counteracted increases in ICAM-1, GRP78, p-PERK/t-PERK, CHOP, SYK, and SRC proteins.
  • SRC overexpression attenuated calycosin's protective effects, indicating SRC's crucial role.

Conclusions:

  • Calycosin effectively attenuates high glucose-induced ER stress and injury in HRGECs.
  • The protective mechanism involves the inhibition of SRC/SYK-dependent ROS signaling.
  • Calycosin demonstrates therapeutic potential for DN, warranting further in vivo investigation.

Related Concept Videos